Stocks
Aerie Pharmaceuticals (AERI) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 451.3% | 275.0% | 917.6% | 2 387% | 2 304% | 1 933% | |||
| Changes by years, y/y, % | -581pp | -176pp | +643pp | +1 470pp | -83pp | +17.4% | |||
Aerie Pharmaceuticals. R&D/CAPEX, %
Aerie Pharmaceuticals. R&D/CAPEX, changes, pp
Aerie Pharmaceuticals (AERI) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | LTM ? | |||
| R&D/CAPEX, % | 1 645% | 2 776% | 1 576% | 1 429% | 2 705% | 1 933% | ||
| Changes by years, y/y, % | -341pp | -366pp | -741pp | -1 541pp | +1 060pp | |||
| Changes by quarters, q/q, % | -1 325pp | +1 131pp | -1 200pp | -148pp | +1 277pp | |||
